Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin Cancer
Clinical trial NCT00601861 · TERMINATED
Trial details
- NCT number
- NCT00601861
- Sponsor
- Novo Nordisk A/S
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-13
- Primary completion
- 2008-06-25
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.